Home › Stocks › AMGN vs GILD
AMGN
Amgen Inc.
$336.23
vs
GILD
Gilead Sciences, Inc.
$132.06

Head-to-Head Comparison

MetricAMGNGILD
Market Cap$155.0B$115.0B
P/E Ratio16.014.0
Div YieldN/AN/A
SectorHealthcareHealthcare
Beta0.430.33
RevenueN/AN/A
Net IncomeN/AN/A
EPSN/AN/A

AI Comparison Brief

AI Generated
Verdict
Gilead Sciences (GILD) emerges as the preferable investment compared to Amgen (AMGN) due to its lower price and beta, indicating a more stable investment with less volatility. GILD's consistent focus on antiviral treatments positions it well for sustained growth, especially with ongoing global health challenges. While both stocks lack concrete metrics like P/E and EPS, GILD's lower beta suggests a more favorable risk/reward profile in the current market.
Key Differences
  • **Valuation and Price**: GILD is priced at $132.06, significantly lower than AMGN's $336.23, making it potentially more accessible for investors looking for value.
  • **Beta and Risk Profile**: GILD has a beta of 0.332 compared to AMGN's 0.435, indicating that GILD's stock is less volatile, offering a safer investment during market fluctuations.
  • **Market Position**: GILD focuses heavily on antiviral drugs, which may provide more growth opportunities in the wake of global health issues, whereas AMGN's product lineup is more diversified but may face more competition.
  • **Dividend Yield**: Both companies currently do not offer dividends, but the lower volatility of GILD may appeal more to risk-averse investors seeking long-term capital appreciation.
Bottom Line
For investors seeking stability and growth potential in the healthcare sector, Gilead Sciences (GILD) is the clear choice, while those willing to take on more risk for a diversified portfolio may consider Amgen (AMGN).
This comparison is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Analysis generated 2026-06-02

Price Chart — AMGN vs GILD

Loading chart...
→ Amgen Inc. (AMGN) Full Analysis → Gilead Sciences, Inc. (GILD) Full Analysis ← Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms